A Comment on IPO Returns

Posted on October 14th, 2018 by Blog Author

The stock market is on its longest bull run in modern history. The biopharma industry, in particular, is in the longest and most active financing window in its history.

Leerink Partners, a leading U.S.-based investment bank specializing in healthcare, recently published a report on the flow of public equity capital into U.S. biopharma stocks over the past 6 years, having analysed the performance[…]

Read More